References
- Abiomed Receives 510(k) Clearance from FDA for Impella 2.5 [Internet]. Cardiology. [cited 2015 May 1]. Available from: http://www.dicardiology.com/article/abiomed-receives-510k-clearance-fda-impella-25
- Garatti A, Colombo T, Russo C. Different applications for left ventricular mechanical support with the Impella Recover 100 microaxial blood pump. J Heart Lung Transplant. 2005;24:481–485.
- Heise CW, Beutler D, Bosak A, et al. Massive atenolol, lisinopril, and chlorthalidone overdose treated with endoscopic decontamination, hemodialysis, impella percutaneous left ventricular assist device, and ECMO. J.Med Toxicol. 2014;11:110–114.
- Donati A, Domizi R, Damiani E, et al. From macrohemodynamic to the microcirculation. Crit Care Res Pract. 2013;2013:892710.
- Hameed SM, Aird WC, Cohn SM. Oxygen delivery. Crit Care Med. 2003;31:S658–S667.
- Engebretsen KM, Morgan MW, Stellpflug SJ, et al. Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome. Clin Toxicol. 2010;48:806–812.
- Cole JB, Stellpflug SJ, Ellsworth H, et al. A blinded, randomized, controlled trial of three doses of high-dose insulin in poison-induced cardiogenic shock. Clin Toxicol. 2013;51:201–207.
- Anderson EA, Hoffman RP, Balon TW, et al. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246–2252.
- Wang GS, Levitan R, Wiegand TJ, et al. Extracorporeal Membrane Oxygenation (ECMO) for severe toxicological exposures: review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2016;12:95--99.
- de Lange DW, Sikma MA, Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol. 2013;51:385–393.